This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

David Guay, PhD
VP Innovation & Technology at Feldan Therapeutics
Speaker

Profile

David Guay is the VP Innovation & Technology at Feldan Therapeutics, a Canadian clinical-stage biotech company that specializes in the development of treatments based on the intracellular delivery of therapeutics. Dr. Guay received his PhD in molecular and cell biology from Laval University and conducted a postdoctoral fellowship in chemical engineering at McGill University. He joined Feldan Therapeutics in 2009 where he led the development and optimization of the Shuttle peptide technology that enables delivery of small molecules, PMOs and proteins to cells, airway epithelia, and basal cell carcinoma.

Agenda Sessions

  • Amphiphilic Shuttle Peptide Enables the Development of PMO-based Therapeutics to Treat Basal Cell Carcinoma and Muco-obstructive Lung Diseases

    , 10:45am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See David at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now